CHAPEL HILL, N.C., May 4, 2018 /PRNewswire/ -- In the pharmaceutical industry, thought leaders play an integral role in everystage of a product's lifecycle. This relationship makes it critical for the Medical Affairs function within pharma to develop robust internal thought leader management capabilities.
Research and consulting leader Best Practices, LLC undertook
More than 65 percent of participants think two Medical Affairs functions have become much more important recently: field-based medical teams and outcomes research/managing real world data. These two functions are among the least outsourced by companies; and while field medical teams get the largest piece of Medical Affairs' budget, outcomes research/managing real world data receives among the smallest allocations, according to the study.
"Developing Strong Internal Thought Leader Management Capabilities Inside Medical Affairs" probes current trends and best practices in thought leader management.
The insights in this report touch on the critical components of creating and maintaining an effective internal approach to thought leader management. This study will:
Thirty-one Medical Affairs leaders at 27 biopharmaceutical companies participated in this research. Responses in this study have been presented in two segments: regional (US only and global companies) and company size (large, medium-sized and small companies).
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/re3349.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
View original content:http://www.prnewswire.com/news-releases/study-explores-how-pharmaceutical-companies-can-create-effective-thought-leader-management-capabilities-300643049.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Kleine Levin (KLS) or sleeping beauty syndrome is a rare neurological disorder that primarly ...
LADA or Latent Autoimmune Diabetes of Adulthood is a form of type 1 autoimmune diabetes that can be ...
Sleep paralysis is a condition where one feels unable to move (paralysis) or speak either when ...View All